Skip to content
Screener

ADMA Biologics ADMA Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable

Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable at other companies

Caterpillar logo
CaterpillarCAT
$2.28M-12.6%
LiveRamp Holdings, Inc. logo
LiveRamp Holdings, Inc.RAMP
$41.38K-43.1%
ADMA Biologics logo
ADMA BiologicsADMA
$2.76M
Community Financial System logo
Community Financial SystemCBU
$1.11M+6.4%
CNO Financial Group logo
CNO Financial GroupCNO
$1.36M-24.1%
Natural Gas Services Group logo
Natural Gas Services GroupNGS
$29.32K-41.1%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.22B-43.3%
Enterprise value$2.29B-40.3%
P/E13.1×-5.6×
P/S4.3×-3.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.

The source filing: ADMA Biologics’s 10-K, filed February 25, 2026.

Filed
Feb 25, 2026, 5:16 PM EST
Fiscal year
FY2025
Accession
0001140361-26-006815
Range of Exercise PricesStock Options Outstanding / Options OutstandingStock Options Outstanding / Weighted Average Remaining Contractual Life (Years)Stock Options Outstanding / Weighted Average Exercise PriceStock Options Outstanding / Aggregate Intrinsic Value ($000's)Stock Options Exercisable / Options OutstandingStock Options Exercisable / Weighted Average Remaining Contractual Life (Years)Stock Options Exercisable / Weighted Average Exercise PriceStock Options Exercisable / Aggregate Intrinsic Value($000's)
$1.10 - $1.67713,7905.8$1.58$10,599636,1856.1$1.59$11,220
$1.84 - $2.76402,6014.8$2.38$6,065382,3305.0$2.38$6,387
$2.83 - $4.2451,368,1765.8$3.45$14,345970,1935.5$3.43$19,684
$4.31 - $6.465987,8917.4$5.34$6,528506,1266.8$5.37$12,718
$6.54 - $9.81300,3288.3$6.54$1,464125,1368.3$6.54$3,514
$13.58 - $20.37909,9979.2$15.56$382142,1659.0$16.12$2,035
4,682,7836.8$3.98$39,3832,762,1356.1$6.19$55,558

Item 16.

FAQ

What is ADMA Biologics's share-based payment arrangement, option, exercise price range, shares exercisable?
ADMA Biologics (ADMA) reported share-based payment arrangement, option, exercise price range, shares exercisable of $2.76M in Q4 2025.
What does share-based payment arrangement, option, exercise price range, shares exercisable mean?
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable

Ask your AI about ADMA Biologics's share-based payment arrangement, option, exercise price range, shares exercisable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude